| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.7B | $6.8B | $6.5B | $4.7B | $1.0B | $0.9B | $0.9B | $1.0B |
| Cost of Revenue | $4.4B | $5.1B | $5.0B | $3.5B | $2.7B | $2.6B | $2.6B | $2.9B |
| Gross Profit | $1.3B | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B |
| Operating Income | $0.5B | $0.9B | $1.0B | $0.9B | $0.1B | $0.3B | $0.0B | $0.0B |
| Net Income | $0.3B | $0.6B | $0.7B | $0.7B | $0.0B | $0.2B | $0.0B | $0.1B |
| EPS (Basic) | $1.75 | $4.05 | $4.58 | $4.01 | $0.28 | $1.48 | $0.25 | $0.64 |
| EPS (Diluted) | $1.73 | $3.99 | $4.49 | $3.90 | $0.27 | $1.44 | $0.24 | $0.63 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.1B | $11.1B | $9.2B | $6.1B | $5.6B | $5.3B | $4.9B | $5.0B |
| Current Assets | $1.4B | $1.9B | $1.6B | $1.1B | $1.0B | $0.9B | $0.9B | $1.0B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $5.6B | $6.4B | $5.3B | $2.8B | $2.7B | $2.7B | $2.6B | $2.6B |
| Current Liabilities | $1.0B | $1.0B | $1.1B | $0.8B | $0.7B | $0.7B | $0.5B | $0.6B |
| Stockholders' Equity | $4.4B | $4.6B | $3.8B | $3.3B | $2.9B | $2.6B | $2.3B | $2.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $0.9B | $0.8B | $0.7B | $0.6B | $0.4B | $0.4B | $0.4B |
| Investing Cash Flow | $-0.5B | $-1.7B | $-2.4B | $-0.5B | $-0.3B | $-0.3B | $-0.3B | $-0.3B |
| Capital Expenditures | $0.3B | $0.6B | $0.4B | $0.3B | $0.3B | — | — | — |
| Financing Cash Flow | $-0.4B | $0.9B | $1.7B | $-0.2B | $-0.3B | $-0.1B | $-0.0B | $-0.2B |